Level A· Stronger Clinical EvidenceSystematic ReviewPubMedOpen access

The Effectiveness of Nanofat in the Management of Skin Scars: A Systematic Review.

Al-Sabri G., Alavi S., Alkaabi S., Maningky M., Forouzanfar T., Helder M.

Systematic Review on Scar, published in Aesthet Surg J Open Forum (2025) — summary generated from the PubMed abstract.

Open my reading list
Level A· Stronger Clinical EvidenceEvidence level of this study

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Systematic Review
Journal
Aesthet Surg J Open Forum (2025)
Country
England
Reported sample size
—
Source database
PubMed
PMID
40800046
PMCID
PMC12343075
DOI
10.1093/asjof/ojaf080

Abstract (original English)

Nanofat is an adipose tissue product obtained through mechanical emulsification, preserving stromal vascular fraction and extracellular matrix. Nanofat has been primarily investigated in the contexts of skin scar repair. This systematic review assesses existing evidence on the effectiveness of nanofat for various skin scar types. In this systematic review, we aim to evaluate the effectiveness of nanofat injections in improving skin scars compared with controls, considering clinical, radiographical, histological, and histomorphometrical outcomes. This systematic review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Databases including MEDLINE, Embase, and the Cochrane Library were searched from January 2013 through March 2025. Studies involving human patients receiving nanofat for scar treatment were included. Risk-of-bias assessments were performed by the Cochrane RoB 2 tool for randomized controlled trials (RCTs) and the NIH Quality Assessment Tool for Pre-Post Studies lacking control groups. Of 415 identified publications, 12 studies were included, comprising 5 RCTs and 7 pre-post intervention studies. Participant numbers ranged from 12 to 48. Most studies reported substantial short-term improvements in scar appearance, texture, and patient satisfaction. Histologically, findings indicated increased skin thicknes

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research